Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats

European Journal of Pharmacology

Volumn 364, Issue 1, 1999, Pages 7-11

  Mayorga, Arthur J ^a   Cousins, Michael S ^a   Trevitt, Jennifer T ^a   Conlan, Aimee ^a   Gianutsos, Gerald ^a   Salamone, John D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Acetylcholine; Motor; Parkinson's disease; Tremor; Vacuous chewing

Indexed keywords

ANTIPARKINSON AGENT; METHOCTRAMINE; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PILOCARPINE; PIRENZEPINE; RECEPTOR SUBTYPE; SCOPOLAMINE; TELENZEPINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; JAW MOVEMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DIAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; JAW; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PILOCARPINE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; SCOPOLAMINE; TREMOR;

EID: 0032926494     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00811-5     Document Type: Article

References (17)

1. 2 through a correlation of in vivo microdialysis and in vitro receptor binding. J. Pharmacol. Exp. Ther. 273:1995;273-279.
2. Carriero D.L., Outslay G., Mayorga A.J., Aberman J.E., Gianutsos G., Salamone J.D. Motor dysfunction produced by tacrine administration in rats. Pharmacol. Biochem. Behav. 58:1997;851-858.
3. Cousins M.S., Carriero D., Salamone J.D. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. Eur. J. Pharmacol. 322:1997;137-145.
4. Cousins, M.S., Finn, M., Carriero, D.L., Conlan, A., Salamone, J.D., in press. The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements: a neurochemical and behavioral study. Pharmacol. Biochem. Behav.
5. Finn M., Jassen A., Baskin P., Salamone J.D. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacol. Biochem. Behav. 57:1996;243-249.
6. 4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J. Neurosci. 14:1994;3351-3363.
7. Kelley A.E., Bakshi V.P., Delfs J.M., Lang C.G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology. 99:1989;542-549.
8. 4 binding sites in rabbit lung, chicken heart and NG108-15 cells. Mol. Pharmacol. 38:1990;805-815.
9. Mayorga A.J., Carriero D.L., Cousins M.S., Gianutsos G., Salamone J.D. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol. Biochem. Behav. 56:1996;273-279.
10. 5) receptor subtype: fact or fiction. Life Sciences. 60:1997;1015-1019.
11. Rupniak N.M.J., Jenner P., Marsden C.D. Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology. 79:1983;226-230.
12. 4 receptors. Emerging Therapeutic Targets. 1:1997;93-95.
13. Salamone J.D., Lalies M.D., Channell S.L., Iversen S.D. Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology. 88:1986;467-471.
14. Salamone J.D., Johnson C.J., McCullough L.D., Steinpreis R.E. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology. 102:1990;529-534.
15. Stewart B.R., Jenner P., Marsden C.D. The pharmacological characterization of pilocarpine-induced chewing in the rat. Psychopharmacology. 96:1988;55-62.
16. Stewart B.R., Jenner P., Marsden C.D. Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behavior. Psychopharmacology. 97:1989;228-234.
17. 4) in rat forebrain. Mol. Pharmacol. 38:1990;267-273.